Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

TEAR:US

1.7000 USD 0.0900 5.03%

As of 20:10:00 ET on 01/28/2015.

Snapshot for TearLab Corp (TEAR)

Open: 1.8000 Day's Range: 1.6601 - 1.8200 Volume: 602,950
Previous Close: 1.7900 52wk Range: 1.5000 - 8.2800 1-Yr Rtn: -74.20%

Stock Chart for TEAR

No chart data available.
  • TEAR:US 1.7000
  • 1D
  • 1M
  • 1Y
1.7900
Interactive TEAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEAR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6300
Est. EPS (USD) (12/2014) -0.6960
Est. PEG Ratio -
Market Cap (M USD) 57.10
Shares Outstanding (M) 33.59
30 Day Average Volume 482,420
Price/Book (mrq) 1.8876
Price/Sale (ttm) 3.0169
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEAR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TEAR

TearLab Corp. is an in-vitro diagnostics company. The Company develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to test for sensitive and specific biomarkers in tears at the point-of-care.

Elias VamvakasChairman/CEOJoseph Jensen "Seph"President/COO
William G DumencuCFO/TreasurerMichael S BergVP:Clinical & Regulatory Ops
More Company Profile & Key Executives for TEAR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • TEAR News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil